Image credit: Nushin Rashidian

Senate Committee Approves McConnell’s Push for a Fast, Lenient FDA Policy on CBD

The bill will “allow rural entrepreneurs an opportunity to start to grow their businesses and create much-needed jobs,” Oregon Sen. Jeff Merkley said during a Senate Appropriations Committee hearing Thursday.

Congress
New York

Leading New York Lawmaker “Optimistic” About Cannabis Legalization’s Chances in 2020

New York Senator Liz Krueger, speaking at a cannabis event on Tuesday evening, also shared where the state’s legalization effort this year went wrong.

Newsletter

More FDA and FTC warnings to CBD sellers • Horizons ETFs: cannabis has lost its “buzz” • & more…

An excerpt from the October 23 edition of the Cannabis Wire Daily newsletter.

Lobbying

The Incredibly Large Lobbying Footprint of Greenwich Biosciences

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states.